SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-21-046415
Filing Date
2021-09-02
Accepted
2021-09-02 16:49:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D ea146876-13da5kidron_oramed.htm SC 13D/A 48318
  Complete submission text file 0001213900-21-046415.txt   49765
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-79895 | Film No.: 211233898
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 W. 57TH ST. NEW YORK NY 10019
Business Address
KIDRON NADAV (Filed by) CIK: 0001351779 (see all company filings)

Type: SC 13D/A